Yoshikatsu Endo

Histone deacetylase inhibitor FR901228 enhances the antitumor effect of telomerase-specific replication-selective adenoviral agent OBP-301 in human lung cancer cells

Takanori Watanabe, Masayoshi Hioki, Toshiya Fujiwara et al. · Experimental Cell Research · 2005 · 88 citations

Medicine, Molecular Biology, Oncology +17

Enhanced antitumor efficacy of telomerase‐selective oncolytic adenoviral agent OBP‐401 with docetaxel: Preclinical evaluation of chemovirotherapy

Toshiya Fujiwara, Shunsuke Kagawa, Hiroyuki Kishimoto et al. · International Journal of Cancer · 2006 · 73 citations

Medicine, Oncology, Pharmacology +13

Impact of lymph node dissection on clinical outcomes of intrahepatic cholangiocarcinoma: Inverse probability of treatment weighting with survival analysis

Yuzo Umeda, Toshiharu Mitsuhashi, Toru Kojima et al. · Journal of Hepato-Biliary-Pancreatic Sciences · 2021 · 42 citations · Full text

Medicine, Oncology, Surgery +17

Preoperative prognostic nutritional index predicts postoperative infectious complications and oncological outcomes after hepatectomy in intrahepatic cholangiocarcinoma

Tatsuo Matsuda, Yuzo Umeda, Tadakazu Matsuda et al. · BMC Cancer · 2021 · 28 citations · Full text

Medicine, Oncology, Surgery +17

A Novel Antiangiogenic Effect for Telomerase-Specific Virotherapy through Host Immune System

Yoshihiro Ikeda, Toru Kojima, Shinji Kuroda et al. · The Journal of Immunology · 2009 · 23 citations · Full text

Medicine, Immunology, Oncology +15